Literature DB >> 18023519

Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.

Yan-Yi Wang1, Xingming Deng, Lijun Xu, Fengqin Gao, Tammy Flagg, W Stratford May.   

Abstract

Bcl2 is a potent antiapoptotic gene that can increase resistance of adult bone marrow hematopoietic progenitor cells to lethal irradiation, and thereby preserve their ability to differentiate. However, the effect of Bcl2 on murine embryonic stem (ES) cells induced to undergo hematopoietic differentiation in the absence of a toxic stress is not known. To test this, murine CCE-ES cells that can be induced to undergo hematopoietic differentiation in a two-step process that results in upregulation of Bcl2 were used. Upregulation of Bcl2 precedes formation of hematopoietic embryoid bodies (EB) and their further differentiation into hematopoietic colony-forming units, when plated as single cells in methylcellulose. ES cells stably expressing a Bcl2 siRNA plasmid to "knock-down" endogenous expression or cells expressing wild-type (WT) Bcl2 or phosphomimetic Bcl2 mutants were examined. ES cells expressing the Bcl2 siRNA or those expressing a dominant-negative, nonphosphorylatable Bcl2 display a strikingly reduced capacity to form hematopoietic EBs and colony-forming units compared to cells expressing WT or phosphomimetic Bcl2 that demonstrate an increased capacity. Bcl2's effect on induced-hematopoietic differentiation of ES cells does not result from either decreased apoptosis or a reduced number of cells. Rather, Bcl2-enhances hematopoietic differentiation of ES cells by upregulating p27, which results in retardation of the cell cycle at G1/G 0. Thus siRNA silencing of p27 reverts Bcl2's enhancement phenotype in a manner similar to that of Bcl2 "silencing" or expression of a nonphosphorylable Bcl2. In addition to Bcl2's well-described antiapoptotic and cell-cycle retardant effect on somatic cells, Bcl2 may also function to enhance induced hematopoietic cell differentiation of murine ES cells. These findings may have potential relevance for expanding hematopoietic stem/progenitor cell numbers from an ES cell source for stem cell transplantation applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023519      PMCID: PMC2253674          DOI: 10.1016/j.exphem.2007.09.004

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  37 in total

1.  Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors.

Authors:  A Rolletschek; H Chang; K Guan; J Czyz; M Meyer; A M Wobus
Journal:  Mech Dev       Date:  2001-07       Impact factor: 1.882

2.  Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells.

Authors:  K Sasaki; S Tamura; H Tachibana; M Sugita; Y Gao; J Furuyama; E Kakishita; T Sakai; T Tamaoki; T Hashimoto-Tamaoki
Journal:  Brain Res Mol Brain Res       Date:  2000-05-05

3.  Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Authors:  Helena Preclíková; Vítezslav Bryja; Jirí Pacherník; Pavel Krejcí; Petr Dvorák; Ales Hampl
Journal:  Cell Growth Differ       Date:  2002-09

4.  Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.

Authors:  G Baldassarre; M V Barone; B Belletti; C Sandomenico; P Bruni; S Spiezia; A Boccia; M T Vento; A Romano; S Pepe; A Fusco; G Viglietto
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

Review 5.  Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21.

Authors:  Maria Marone; Giuseppina Bonanno; Sergio Rutella; Giuseppe Leone; Giovanni Scambia; Luca Pierelli
Journal:  Leuk Lymphoma       Date:  2002-01

6.  Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation.

Authors:  C W Chiang; G Harris; C Ellig; S C Masters; R Subramanian; S Shenolikar; B E Wadzinski; E Yang
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 7.  Phosphorylation of Bcl2 and regulation of apoptosis.

Authors:  P P Ruvolo; X Deng; W S May
Journal:  Leukemia       Date:  2001-04       Impact factor: 11.528

8.  Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases.

Authors:  X Deng; P Ruvolo; B Carr; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

9.  Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo.

Authors:  Hanna K A Mikkola; Yuko Fujiwara; Thorsten M Schlaeger; David Traver; Stuart H Orkin
Journal:  Blood       Date:  2002-09-19       Impact factor: 22.113

10.  Expression of CD41 on hematopoietic progenitors derived from embryonic hematopoietic cells.

Authors:  Maria Teresa Mitjavila-Garcia; Michel Cailleret; Isabelle Godin; Maria Manuela Nogueira; Karine Cohen-Solal; Valérie Schiavon; Yann Lecluse; Françoise Le Pesteur; Anne Hélène Lagrue; William Vainchenker
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more
  8 in total

1.  Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector.

Authors:  Jeong Hyun; Monica Grova; Hossein Nejadnik; David Lo; Shane Morrison; Daniel Montoro; Michael Chung; Andrew Zimmermann; Graham G Walmsley; Min Lee; Heike Daldrup-Link; Derrick C Wan; Michael T Longaker
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

2.  Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2.

Authors:  Andrew B Sharabi; Sung-Hyung Lee; Margaret A Goodell; Xue F Huang; Si-Yi Chen
Journal:  Cloning Stem Cells       Date:  2009-12

Review 3.  Getting away with murder: how does the BCL-2 family of proteins kill with immunity?

Authors:  Thibaud T Renault; Jerry E Chipuk
Journal:  Ann N Y Acad Sci       Date:  2013-03-25       Impact factor: 5.691

4.  Sera from children with autism alter proliferation of human neuronal progenitor cells exposed to oxidation.

Authors:  Bozena Mazur-Kolecka; Ira L Cohen; Edmund C Jenkins; Michael Flory; George Merz; W Ted Brown; Janusz Frackowiak
Journal:  Neurotox Res       Date:  2009-04-18       Impact factor: 3.911

5.  Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription.

Authors:  S Huseby; G Gausdal; T J Keen; E Kjærland; C Krakstad; L Myhren; K Brønstad; C Kunick; F Schwede; H-G Genieser; R Kleppe; S O Døskeland
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

6.  PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis.

Authors:  X Cheng; R L Bennett; X Liu; M Byrne; W Stratford May
Journal:  Blood Cancer J       Date:  2013-09-06       Impact factor: 11.037

7.  Improved Survival and Hematopoietic Differentiation of Murine Embryonic Stem Cells on Electrospun Polycaprolactone Nanofiber.

Authors:  Nima Dehdilani; Karim Shamsasenjan; Aliakbar Movassaghpour; Parvin Akbarzadehlaleh; Bahram Amoughli Tabrizi; Hamed Parsa; Fatemeh Sabagi
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

8.  Key genes and integrated modules in hematopoietic differentiation of human embryonic stem cells: a comprehensive bioinformatic analysis.

Authors:  Pengfei Li; Mengyao Wu; Qiwang Lin; Shu Wang; Tong Chen; Hua Jiang
Journal:  Stem Cell Res Ther       Date:  2018-11-08       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.